MedTrace Logo

A Four Month Home Based tDCS Study on Patients With Alzheimer's Disease.

NCT04759092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-10-11

No results posted yet for this study

Summary

The study is an open label study on patients with Alzheimer's dementia using home based transcranial direct current (tDCS) stimulation. Aims of the study is to investigate applicability and effect of treatment.

Conditions

  • Alzheimer Disease

Interventions

DEVICE

transcranial direct current stimulation (tDCS)

Apply 30min low dose (2mA) transcranial current stimulation on the scalp every day for four months.

Sponsors & Collaborators

  • University of Tromso

    collaborator OTHER

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Ole K Grønli Grønli, MD/PHD · University Hospital of North Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759092 on ClinicalTrials.gov